KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Q3 2025 value amounting to 0.02%.

  • Jazz Pharmaceuticals' Return on Capital Employed fell 800.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.07% for FY2024, which is 100.0% up from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Return on Capital Employed is 0.02%, which was down 800.0% from 0.0% recorded in Q2 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Return on Capital Employed peaked at 0.12% during Q1 2021, and registered a low of 0.02% during Q3 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' median Return on Capital Employed value was 0.02% (recorded in 2021), while the average stood at 0.03%.
  • Per our database at Business Quant, Jazz Pharmaceuticals' Return on Capital Employed soared by 800bps in 2021 and then crashed by -1200bps in 2022.
  • Quarter analysis of 5 years shows Jazz Pharmaceuticals' Return on Capital Employed stood at 0.01% in 2021, then plummeted by -146bps to 0.01% in 2022, then soared by 975bps to 0.06% in 2023, then grew by 9bps to 0.06% in 2024, then plummeted by -131bps to 0.02% in 2025.
  • Its Return on Capital Employed stands at 0.02% for Q3 2025, versus 0.0% for Q2 2025 and 0.06% for Q4 2024.